AzTrials
AzTrials

Exercise-Induced Laryngeal ObstructionHALOSNCT05314478

Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies

A study testing Continuous laryngoscopy during exercise test using the HALOS headgear in people with Exercise-Induced Laryngeal Obstruction, run by Liverpool University Hospitals NHS Foundation Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Exercise-induced laryngeal obstruction (EILO) is a condition in which the larynx, or voice box, narrows during high-intensity exercise, and is often mis-diagnosed. A test called a Continuous Laryngoscopy during Exercise (CLE) test can be performed, where a flexible camera is inserted through the nose and positioned at… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Exercise-Induced Laryngeal Obstruction
What is being tested?
Continuous laryngoscopy during exercise test using the HALOS headgear
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
24 Mar 2022to 25 Aug 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participant is willing and able to give informed consent for participation in the study.
  • Male, female or non-binary, aged 18 years or above.
  • Able (in the Investigators opinion) and willing to comply with all study requirements.
  • Able to undergo a CLE test as judged by the clinician, and where a clinical need of the test for the delivery of healthcare has been identified.

Who cannot join

  • Pain, sore areas, broken skin at the site of contact with the headgear.
  • Devices, e.g. cochlear implants, that impede the use of the headgear.
  • Head circumference is less than 50cm or greater than 63cm, reflecting the 3rd centile for females and 97th centile for males, respectively (Bushby, 1992).
  • Skull base/facial surgery or fracture within the previous six weeks
  • Major or life threatening epistaxis within the previous six weeks
  • Trauma to nasal cavity secondary to surgery or injury within the previous six weeks
Show all 14Show fewer
  • Sino-nasal and anterior skull base tumours/surgery
  • Nasopharyngeal stenosis
  • Craniofacial anomalies
  • Hereditary haemorrhagic telangiectasia
  • Severe movement disorders and/or severe agitation
  • Vasovagal history
  • Bleeding risks
  • Any other exclusion criteria as identified by the current endoscopy procedure.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Liverpool University Hospitals Nhs Foundation Trust

    Liverpool, Merseyside, L7 8XP

Other trials in United Kingdom

About this study

Official title: Safe and Effective Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies (HALOS) - a Device Development Study

Exercise-induced laryngeal obstruction (EILO) is a condition in which the larynx, or voice box, narrows during high-intensity exercise, and is often mis-diagnosed. A test called a Continuous Laryngoscopy during Exercise (CLE) test can be performed, where a flexible camera is inserted through the nose and positioned at the back of the throat. While the patient exercises, the camera image can be used to identify the presence of EILO.

During the CLE test it is important that the part of the camera that remains outside the body is held securely in position near the forehead so that a clear and stable image is obtained using a headgear to secure the camera to the patient's head.

Read more

There are no headgears available on the market, so we have designed and manufactured one called HALOS (Headgear Accessory for Exercise-Induced Laryngeal Obstruction Studies).

This study is to ensure that HALOS is suitable for use, and to check we have understood and minimised the risks associated with the headgear. The headgear can then be used routinely within the Trust, improving the care that offered to patients.

We will recruit 30 male or female participants who need to undergo a CLE test. The study will be conducted at Broadgreen Hospital, Liverpool, UK. Before the CLE test, participants will attend a screening appointment to discuss the procedure. There will be no follow-up appointments.

During the CLE test, the participants will wear the HALOS headgear while exercising, and the clinician will monitor the image from the camera for signs of EILO. After the test, participants will be asked how tolerable the headgear was, and if they have any concerns about any aspect of it. The clinician will also record how clear and stable the camera image was, how easy it was to use, and any concerns about any aspect of it.

Being tested
Continuous laryngoscopy during exercise test using the HALOS headgear
Keywords
Laryngoscopy, Exercise-Induced, Laryngeal Obstruction, Headgear

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Continuous laryngoscopy during exercise test using the HALOS headgearDevice

    The participant will undergo the CLE test following standard clinical practice.

    The order of events of the aspects of the investigation related to the headgear will be:

    1. The headgear is prepared for use.
    2. The headgear is fitted onto the participant's head.
    3. The endoscope is inserted into the participant.
    4. The endoscope is fitted onto the headgear.
    5. The CLE test is carried out.
    6. The endoscope is removed from the headgear.
    7. The endoscope is removed from the participant.
    8. The headgear is removed from the participant.
    9. The headgear is cleaned and stored.
Study groups in NCT05314478
Study groupRoleWhat they receive
ParticipantsExperimentalParticipants will be required to attend a single consultation and screening appointment to discuss the investigation procedure, and this will occur at least a week before the Continuous Laryngoscopy during Exercise (CLE) test. Participants will then attend one appointment for the CLE test. There will be no follow up assessments using the headgear.
Receives: Device: Continuous laryngoscopy during exercise test using the HALOS headgear

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Participants With Continuous Laryngoscopy During Exercise Tests

    The percentage of participants with continuous laryngoscopy during exercise tests where the endoscopy image was clear and stable enough to allow a diagnosis of exercise-induced laryngeal obstruction to be confirmed or ruled out.

    Measured: 30 minutes

Secondary outcomes (4)
  1. Percentage of Participants With Device Usability Rating of 4 or 5

    The percentage of participants where the clinician provided a device usability rating of 4 or 5 on the post-test questionnaire. Device usability is scored on a five-point LIKERT scale ranging from 1 (very hard to use) to 5 (very easy to use).

    Measured: 60 minutes

  2. Device Usability Subjective Feedback

    Focussing on any clinician-reported concerns regarding set-up, operation and cleaning.

    Measured: 60 minutes

  3. Percentage of Participants Scoring Device Tolerability as 3 or 4

    The percentage of participants where the participant provided a device tolerability rating of 3 or 4 on the post-test questionnaire. Device tolerability is scored on a four-point scale of 1 (highly intolerable), 2 (intolerable), 3 (tolerable) or 4 (highly tolerable).

    Measured: 60 minutes

  4. Device Tolerability Subjective Feedback

    Focussing on any participant-reported concerns regarding the comfort of the headgear including how hot their head felt, weight of the headgear, how secure the headgear felt and the impact of the headgear on their performance during the investigation.

    Measured: 60 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2022
  2. Study start24 Mar 2022
  3. Primary completion25 Aug 2023
  4. Study completion25 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
The study is an interventional clinical trial involving a single group of 30 participants undergoing a continuous laryngoscopy during exercise test with the HALOS headgear.
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05314478
Sponsor's protocol ID
SP0707
Acronym
HALOS
Status last verified
Oct 2023
First submitted
30 Mar 2022
Last updated
8 Nov 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Continuous laryngoscopy during exercise test using the HALOS headgear in people with Exercise-Induced Laryngeal Obstruction, run by Liverpool University Hospitals NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Nov 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Participants With Continuous Laryngoscopy During Exercise Tests (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in